These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 28032603)

  • 1. Hypoxia induced Bcl-2/Twist1 complex promotes tumor cell invasion in oral squamous cell carcinoma.
    Duan Y; He Q; Yue K; Si H; Wang J; Zhou X; Wang X
    Oncotarget; 2017 Jan; 8(5):7729-7739. PubMed ID: 28032603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma.
    Sun T; Sun BC; Zhao XL; Zhao N; Dong XY; Che N; Yao Z; Ma YM; Gu Q; Zong WK; Liu ZY
    Hepatology; 2011 Nov; 54(5):1690-706. PubMed ID: 21748764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
    Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
    Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia induced epithelial-mesenchymal transition and vasculogenic mimicry formation by promoting Bcl-2/Twist1 cooperation.
    Liu K; Sun B; Zhao X; Wang X; Li Y; Qiu Z; Gu Q; Dong X; Zhang Y; Wang Y; Zhao N
    Exp Mol Pathol; 2015 Oct; 99(2):383-91. PubMed ID: 26318343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
    Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
    J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
    Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
    Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymosin β4 induces proliferation, invasion, and epithelial-to-mesenchymal transition of oral squamous cell carcinoma.
    Hong KO; Lee JI; Hong SP; Hong SD
    Amino Acids; 2016 Jan; 48(1):117-27. PubMed ID: 26276576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
    Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
    Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
    Chen SY; Teng SC; Cheng TH; Wu KJ
    Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
    Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
    Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
    Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
    Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
    Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
    Yu J; Xie F; Bao X; Chen W; Xu Q
    Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
    Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
    Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
    Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW
    Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target.
    da Silva SD; Alaoui-Jamali MA; Soares FA; Carraro DM; Brentani HP; Hier M; Rogatto SR; Kowalski LP
    Cancer; 2014 Feb; 120(3):352-62. PubMed ID: 24150986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation.
    Yang WH; Su YH; Hsu WH; Wang CC; Arbiser JL; Yang MH
    Oncogene; 2016 May; 35(18):2287-98. PubMed ID: 26257063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.